ALT in the 13F filings
Altimmune Inc · CUSIP 02155H200
- Quarter end
- 31 Dec 2022
- the date the book describes
- Filed
- 14 Feb 2023
- latest of these filings; the earliest 14 Feb 2023
- Managers listing it
- 5
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q3 2022 and Q4 2022; 4 listed it in both
- Shares listed
- 8,078,994
- combined, among listed positions
- Reported value
- $133m
- combined, at the quarter end
Managers listing ALT in Q4 2022
5 of 5 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Janus Henderson Group Ltd | 3,833,579 | $63m | under 0.1% | Trimmed | -288,235 | 14 Feb 2023 (the filing on sec.gov) |
| Woodline Partners LP | 1,304,024 | $21m | 0.29% | Added | +285,933 | 14 Feb 2023 (the filing on sec.gov) |
| Marshall Wace LLP | 1,239,794 | $20m | under 0.1% | Added | n.a. | 14 Feb 2023 (the filing on sec.gov) |
| Two Sigma Advisers LP | 925,300 | $15m | under 0.1% | Added | +56,500 | 14 Feb 2023 (the filing on sec.gov) |
| Two Sigma Investments LP | 776,297 | $13m | under 0.1% | Trimmed | -201,350 | 14 Feb 2023 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Woodline Partners LPexisting position · 1,304,024 shares now+285,933
- Two Sigma Advisers LPexisting position · 925,300 shares now+56,500
Reductions
- Janus Henderson Group Ltdexisting position · 3,833,579 shares now-288,235
- Two Sigma Investments LPexisting position · 776,297 shares now-201,350
New positions and exits
New (0)
No new position among listed positions.
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 1 | $8.4m | n.a. | n.a. |
| Q3 2020 | 1 | $952k | n.a. | n.a. |
| Q2 2021 | 1 | $15m | n.a. | n.a. |
| Q3 2021 | 1 | $3.9m | n.a. | n.a. |
| Q4 2021 | 2 | $6.8m | n.a. | n.a. |
| Q1 2022 | 2 | $5.9m | n.a. | n.a. |
| Q2 2022 | 2 | $8.0m | n.a. | n.a. |
| Q3 2022 | 4 | $89m | n.a. | n.a. |
| Q4 2022 | 5 | $133m | n.a. | n.a. |
| Q4 2023 | 1 | $382k | 1 | 0 |
| Q1 2024 | 2 | $7.0m | 2 | 0 |
| Q2 2024 | 1 | $184k | 0 | 1 |
| Q3 2024 | 1 | $169k | 0 | 0 |
| Q4 2024 | 1 | $199k | 0 | 0 |
| Q1 2025 | 1 | $138k | 0 | 0 |
| Q2 2025 | 1 | $107k | 0 | 0 |
| Q3 2025 | 1 | $104k | 0 | 0 |
| Q4 2025 | 1 | $100k | 14 | 9 |
| Q1 2026 | 1 | $85k | 10 | 12 |
| Q2 2026 | 1 | $20m | 20 | 7 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALT and LLY →ALT and JNJ →ALT and VRTX →Choose a stock to compare with ALT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALT, latest filings →Back to the 13F Explorer →